Compare SLGN & TECH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SLGN | TECH |
|---|---|---|
| Founded | 1987 | 1976 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Containers/Packaging | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.1B | 8.6B |
| IPO Year | 1994 | 1995 |
| Metric | SLGN | TECH |
|---|---|---|
| Price | $37.94 | $47.61 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 9 | 11 |
| Target Price | $52.78 | ★ $71.82 |
| AVG Volume (30 Days) | 738.6K | ★ 3.2M |
| Earning Date | 04-29-2026 | 05-06-2026 |
| Dividend Yield | ★ 2.02% | 0.62% |
| EPS Growth | ★ 4.65 | N/A |
| EPS | 0.60 | ★ 0.81 |
| Revenue | ★ $4,489,927,000.00 | $1,219,635,000.00 |
| Revenue This Year | $4.99 | $2.49 |
| Revenue Next Year | $2.20 | $6.40 |
| P/E Ratio | $63.53 | ★ $59.38 |
| Revenue Growth | 0.92 | ★ 5.23 |
| 52 Week Low | $36.15 | $43.20 |
| 52 Week High | $57.04 | $72.16 |
| Indicator | SLGN | TECH |
|---|---|---|
| Relative Strength Index (RSI) | 43.05 | 44.31 |
| Support Level | $37.10 | $43.20 |
| Resistance Level | $42.09 | $57.86 |
| Average True Range (ATR) | 1.15 | 2.27 |
| MACD | -0.02 | 0.28 |
| Stochastic Oscillator | 35.35 | 57.18 |
Silgan Holdings Inc is a manufacturer of sustainable rigid packaging solutions for the world's essential consumer goods products. Its products include: dispensing and specialty closures for fragrance and beauty, food, beverage, personal and health care, home care and lawn and garden products; steel and aluminum containers for pet and human food and general line products; and custom designed plastic containers for pet and human food, consumer health and pharmaceutical, personal care, home care, lawn and garden and automotive products.
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (about 75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.